MSE
JAZZ icon

MUFG Securities EMEA’s Jazz Pharmaceuticals JAZZ Stock Holding History

MUFG Securities EMEA’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-55,200
Closed -$5.51M – 458
2020
Q1 		$5.51M Buy
55,200
+22,200
+67% +$2.87M 0.06% 189
2019
Q4 		$4.93M Buy
33,000
+8,400
+34% +$1.14M 0.04% 280
2019
Q3 		$3.15M Buy
+24,600
New +$3.3M 0.04% 211
2019
Q2 		– Sell
-24,151
Closed -$3.45M – 457
2019
Q1 		$3.45M Sell
24,151
-95,500
-80% -$12.5M 0.04% 250
2018
Q4 		$14.8M Buy
+119,651
New +$17.7M 0.15% 88

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MUFG Securities EMEA's JAZZ Position: Q2 2020 in Review

MUFG Securities EMEA sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 55,200 shares — an estimated $5.51M sold.

MUFG Securities EMEA first reported a position in JAZZ in Q4 2018 and held it in 5 quarters. The position peaked at $14.8M in Q4 2018. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • MUFG Securities EMEA reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • MUFG Securities EMEA sold 55,200 Jazz Pharmaceuticals shares in Q2 2020, an estimated $5.51M.
  • MUFG Securities EMEA first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • MUFG Securities EMEA's Jazz Pharmaceuticals position peaked at $14.8M in Q4 2018.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on MUFG Securities EMEA's 13F filing for Q2 2020, filed 13 Aug 2020.